Computational Genomics & NGS

Clinical Genomics

AI-Powered Clinical Genomics Analysis for Precision Medicine, Rare Disease Diagnosis & Translational Research

Clinical Genomics

RASA Life Science Informatics provides advanced Clinical Genomics analysis services that transform genomic data into clinically actionable insights for precision medicine, rare disease research, oncology, and translational healthcare applications.

Our bioinformatics workflows integrate Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), targeted sequencing, transcriptomics, and clinical data to identify disease-associated variants, prioritize therapeutic targets, support molecular diagnostics, and enable patient stratification.

We help hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology organizations, CROs, and research institutes accelerate clinical research and precision medicine initiatives through scalable, secure, and reproducible genomics analytics.

Service Offerings

Clinical Genomics Services

Rare Disease Genomics

Identify genetic variants associated with inherited and rare disorders.

  • Rare variant discovery
  • Family-based analysis
  • Trio sequencing analysis
  • Candidate gene prioritization
  • Phenotype-driven interpretation
  • Mendelian disease analysis

Cancer Genomics

Comprehensive genomic profiling to support precision oncology research and clinical decision-making.

  • Somatic mutation analysis
  • Tumor-normal comparison
  • Driver mutation identification
  • Tumor mutational burden (TMB)
  • Mutational signature analysis
  • Actionable variant discovery

Clinical Variant Interpretation

Translate genomic variants into meaningful biological and clinical insights.

  • Variant annotation
  • ACMG classification
  • Pathogenicity assessment
  • Literature-based evidence review
  • Clinical significance evaluation
  • Variant prioritization

Pharmacogenomics

Understand genetic factors influencing drug response and treatment outcomes.

  • Drug-gene interaction analysis
  • Pharmacogenomic biomarker identification
  • Personalized treatment support
  • Adverse drug response prediction
  • Therapeutic optimization

Precision Medicine Analytics

Integrate genomic and clinical information for personalized healthcare applications.

  • Patient stratification
  • Molecular subtyping
  • Biomarker-guided treatment insights
  • Clinical outcome prediction
  • Translational research support
Capabilities

Key Features

Rare Disease & Cancer Genomics Expertise
Clinical Variant Interpretation
Pharmacogenomics Analysis
Precision Medicine Analytics
ACMG-Compliant Variant Classification
AI-Assisted Variant Prioritization
Secure & Reproducible Workflows
Publication-Ready Reports & Visualizations
Deliverables

Deliverables

Clinical Genomics Reports

Annotated Variant Reports
ACMG Classification Reports
Pathogenicity Assessments
Candidate Disease Variant Lists
Pharmacogenomic Reports

Precision Medicine Outputs

Molecular Profiling Reports
Biomarker Identification
Patient Stratification Analysis
Therapeutic Insight Reports
Clinical Research Summaries

Visualization & Reporting

Variant Distribution Plots
Mutation Landscape Visualizations
Pathway Analysis Reports
Publication-Ready Figures
Executive Scientific Reports
Applications

Applications

Rare Disease Research

Identification and interpretation of disease-causing genetic variants.

Precision Oncology

Tumor profiling and actionable mutation discovery.

Clinical Diagnostics Research

Variant interpretation and translational genomics studies.

Pharmacogenomics

Personalized treatment and drug response prediction.

Precision Medicine Programs

Patient-specific molecular characterization and stratification.

Biomarker Discovery

Identification of diagnostic, prognostic, and predictive biomarkers.

Technology

Technologies & Databases

Variant Analysis

GATK
DeepVariant
FreeBayes
bcftools

Clinical Annotation

ClinVar
OMIM
HGMD
Ensembl VEP
ANNOVAR

Cancer Genomics Resources

COSMIC
TCGA
cBioPortal
OncoKB

Pharmacogenomics Resources

PharmGKB
CPIC
DrugBank

Infrastructure

Nextflow
Snakemake
Docker
AWS
Google Cloud
HPC Clusters
Highlights

Representative Analysis Outputs

Rare Disease Variant Discovery

Identification of causative variants associated with inherited disorders.

Precision Oncology Profiling

Detection of clinically relevant somatic mutations and biomarkers.

Pharmacogenomic Analysis

Assessment of drug-response associated genetic variants.

Precision Medicine Insights

Patient-specific molecular characterization and stratification.

Translational Genomics Research

Integration of genomic findings with clinical outcomes and disease phenotypes.

Why RASA

Why Choose RASA?

AI-Assisted Bioinformatics

Machine learning-enabled workflows for biomarker discovery, variant prioritization, and predictive genomics.

Multi-Platform Expertise

Support for Illumina, Oxford Nanopore, PacBio HiFi, and 10x Genomics platforms.

End-to-End Analysis

From raw sequencing data to biological interpretation and publication-ready reports.

Cloud-Ready Infrastructure

Deployable on AWS, Google Cloud, HPC clusters, and secure on-premise environments.

Reproducible Workflows

Built using Nextflow, Snakemake, Docker, and Singularity for enterprise-grade bioinformatics operations.

Service FAQ

Frequently Asked Questions

Clinical Genomics is the application of genomic sequencing technologies and bioinformatics analysis to understand the genetic basis of disease, support clinical research, and enable precision medicine. By analyzing DNA and RNA sequencing data, Clinical Genomics helps identify disease-associated variants, predict therapeutic response, discover biomarkers, and improve patient stratification.

Services include Whole Genome Sequencing (WGS) Analysis, Whole Exome Sequencing (WES) Analysis, Clinical Variant Interpretation, Rare Disease Genomics, Cancer Genomics, Pharmacogenomics Analysis, Precision Medicine Analytics, Biomarker Discovery, Multi-Omics Clinical Integration, and Patient Stratification Studies.

Yes. We provide advanced rare disease genomics analysis including trio analysis, family-based sequencing analysis, variant prioritization, phenotype-driven interpretation, candidate gene discovery, and clinical annotation.

WGS analyzes the entire genome, including coding and non-coding regions, while WES focuses on protein-coding regions that contain most known disease-causing mutations.

Yes. We perform comprehensive variant annotation and interpretation using internationally recognized databases and guidelines.

ClinVar, OMIM, gnomAD, HGMD, Ensembl VEP, ANNOVAR, PharmGKB, COSMIC, TCGA, and OncoKB.

Pharmacogenomics studies how genetic variation influences drug response, helping optimize treatment strategies and reduce adverse drug reactions.

Yes. Services include somatic variant analysis, tumor-normal comparison, driver mutation identification, tumor mutational burden analysis, mutational signature analysis, and precision oncology biomarker discovery.

Yes. Clinical Genomics helps identify patient-specific molecular signatures, discover biomarkers, and support personalized treatment strategies.

Clinical Genomics enables identification of disease-causing variants associated with inherited disorders using WGS, WES, and phenotype-driven interpretation.

Precision oncology uses genomic information to identify actionable mutations, biomarkers, and therapeutic targets for personalized cancer research and treatment.

Yes. Clinical genomics can identify predictive biomarkers associated with treatment response, drug resistance, toxicity, and disease progression.

Patient stratification groups patients based on genomic and clinical characteristics to improve clinical trial design and personalized medicine strategies.

Yes. It is widely used to identify biomarkers, stratify patients, characterize disease subtypes, and support precision medicine-based clinical trial design.

RASA combines expertise in genomics, bioinformatics, AI-driven analytics, biomarker discovery, precision medicine, and multi-omics integration to deliver scalable and publication-ready solutions.

Ready to partner with a trusted bioinformatics company in India?

Get in touch with our team in Pune, India to discuss sample sizes, platform details, and custom bioinformatics pipeline configurations for your research program.

Start a Project